A. Triterpene alcohols and sterols from rice bran lower postprandial glucose-dependent insulinotropic polypeptide release and prevent diet-induced obesity in mice. J Appl Physiol 117: 1337-1348, 2014. First published September 25, 2014 doi:10.1152/japplphysiol.00268.2014.-Obesity is now a worldwide health problem. Glucose-dependent insulinotropic polypeptide (GIP) is a gut hormone that is secreted following the ingestion of food and modulates energy metabolism. Previous studies reported that lowering diet-induced GIP secretion improved energy homeostasis in animals and humans, and attenuated diet-induced obesity in mice. Therefore, food-derived GIP regulators may be used in the development of foods that prevent obesity. Rice bran oil and its components are known to have beneficial effects on health. Therefore, the aim of the present study was to clarify the effects of the oil-soluble components of rice bran on postprandial GIP secretion and obesity in mice. Triterpene alcohols [cycloartenol (CA) and 24-methylene cycloartanol (24Me)], ␤-sitosterol, and campesterol decreased the dietinduced secretion of GIP in C57BL/6J mice. Mice fed a high-fat diet supplemented with a triterpene alcohol and sterol preparation (TASP) from rice bran for 23 wk gained less weight than control mice. Indirect calorimetry revealed that fat utilization was higher in TASP-fed mice than in control mice. Fatty acid oxidation-related gene expression in the muscles of mice fed a TASP-supplemented diet was enhanced, whereas fatty acid synthesis-related gene expression in the liver was suppressed. The treatment of HepG2 cells with CA and 24Me decreased the gene expression of sterol regulatory element-binding protein (SREBP)-1c. In conclusion, we clarified for the first time that triterpene alcohols and sterols from rice bran prevented diet-induced obesity by increasing fatty acid oxidation in muscles and decreasing fatty acid synthesis in the liver through GIP-dependent and GIPindependent mechanisms. cycloartenol; GIP; obesity; triterpene alcohol THE NUMBER OF OBESE PEOPLE has been increasing worldwide at an unprecedented pace. Obesity can lead to more serious diseases such as diabetes, heart attacks, cerebral stroke, and some cancers (15, 16, 43) . Modern lifestyles characterized by the westernization of dietary habits and lack of physical activities are the main cause of the high prevalence of obesity. Therefore, lifestyle changes that ameliorate or prevent obesity, notably dietary content, are often recommended for the primary prevention and treatment of these diseases.
notropic polypeptide (GIP) levels. GIP is a gut hormone that is secreted from enteroendocrine K cells, which are predominantly located in the intestinal epithelium of the proximal duodenum (42) . The secretion of GIP is stimulated by the access of secretagogues such as dietary fat, carbohydrates, and proteins to the luminal surface of K cells (42) . The primary action of GIP is to potentiate glucose-stimulated insulin secretion from pancreatic ␤-cells. In addition to pancreatic ␤-cells as the classical target of GIP, the GIP receptor (GIPR) is located on various extrapancreatic organs, including adipose tissue (34) . Previous studies demonstrated that GIP mediated various anabolic effects on adipocytes, including the stimulation of glucose uptake (13, 39) , lipoprotein lipase (LPL) activity (19 -21) , and fatty acid synthesis (29) . Furthermore, recent studies in mice implicated GIP in the regulation of energy metabolism and subsequent obesity-related phenotypes (11, 23, 24, 25) . The prevention of high-fat diet-induced obesity accompanied by increased fat utilization has been observed in genetically GIPR-ablated mice (24) . Furthermore, a daily injection of the specific GIPR antagonist, (Pro3)GIP, to high-fat diet-fed obese mice resulted in a decrease in body weight and adipose tissue mass accompanied by improvements in insulin sensitivity and the normalization of glucose tolerance (11, 23) .
Not only the inhibition of GIP signaling but also a decrease in the secretion of GIP have been shown to prevent dietinduced obesity. The genetic ablation of GIP-secreting K cells enhanced energy expenditure and prevented high-fat diet-induced obesity in mice (3) . In contrast, we previously demonstrated that the increase in blood GIP levels induced by the chronic administration of GIP decreased fat utilization in high-fat diet-fed mice (37) . Our previous studies also revealed that the administration of dietary components that lowered postprandial blood GIP levels, such as diacylglycerol (35) , 1-monoolein (36) , and RS4-type resistant starch (37) increased fat catabolism and prevented high-fat diet-induced obesity in mice. Postprandial fat utilization was higher with the intake of either diacylglycerol (35) or RS4 (37) than with its equivalent control oil or carbohydrate in humans. These findings indicated that reducing postprandial GIP levels may contribute to the attenuation of obesity due to enhanced fat utilization and reduced anabolic signaling on adipocytes. Accordingly, we have examined food components that regulate the postprandial secretion of GIP.
Rice is consumed as a staple food in Asian countries. Unpolished brown rice contains various nutrients in its bran and germ layer, all of which are removed in the process of producing polished white rice. In modern lifestyles, white rice is preferably eaten over brown rice because of its mild flavor and soft texture. Nevertheless, due to the recent increase in the rate of obesity and relevant diseases, brown rice and its components have started to attract a lot of attention as a natural food that is considered to be beneficial for health. Rice bran contains various nutrient components such as minerals, fibers, fatty acids, and oil-soluble nutraceuticals (5) . Triterpene alcohols and plant sterols, as well their ferulic acid esters (␥-oryzanol), are characteristic components of rice bran oil, which has been shown to exhibit several physiological actions, such as hypocholesterolemic (33) , antioxidant (17) , anti-inflammatory (2) , and anticarcinogenic (44) effects. Even though rice bran oil has been a research focus for its physiological actions and application to healthy foods, little is known about the effects of fat-soluble rice bran components on energy metabolism and obesity.
Therefore, we examined the effects of fat-soluble components from rice bran on postprandial GIP secretion and high-fat diet-induced obesity in C57BL/6J mice to determine their beneficial effects on energy metabolism.
MATERIALS AND METHODS

Materials.
All reagents for experiments were purchased from Sigma-Aldrich Japan (Tokyo, Japan), unless otherwise stated. A commercially available triterpene alcohol and sterol preparation (TASP) of food grade was purchased from Oryza Oil & Fat Chemical (Oryza Triterpenoid-P Lot B-702, Aichi, Japan). The composition of TASP was determined by gas chromatography. The triterpene alcohol and sterol composition in TASP was cycloartenol (CA)/24-methylene cycloartanol (24Me)/␤-sitosterol (SS)/campesterol (CS) ϭ 19/33/ 13/16 (%). Triterpene alcohols (CA and 24Me) or their ferulic acid esters [cycloartenol ferulate (CA-F) and 24-methylene cycloartanol ferulate (24Me-F)] were purified from TASP or ␥-oryzanol (Tsuno Rice Fine Chemicals, Wakayama, Japan) by silica gel and octadecylsilyl HPLC column chromatography. The oleic acid esters [cycloartenol oleate (CA-O) and 24-methylene cycloartenol oleate (24Me-O)] were synthesized from triterpene alcohols and oleoyl chloride. SS and CS were purchased from Wako Pure Chemical Industries (Osaka, Japan). Sulfo-N-succinimidyl oleate (SSO), an inhibitor of FAT/CD36 (6, 32) , was synthesized as reported previously (12) .
Animals. Male C57BL/6J mice (7-10 wk old; CLEA Japan, Tokyo, Japan) were housed at four per cage in plastic cages. Animals were fed a standard chow diet consisting of 3.47 kcal/g, with 4.6% fat, 51.4% carbohydrate, and 24.9% protein (CE-2; CLEA Japan). Food and water were provided ad libitum in a room maintained at 23°C, with a relative humidity of 55 Ϯ 10% and a daily photoperiod from 0700 to 1900. All animals were housed for 1-2 wk before use. All animal experiments were conducted in the Experimental Animal Facility of Kao Tochigi Institute. The Animal Care Committee of Kao Tochigi Institute approved the present study. All experiments strictly followed the guidelines of this committee. The handling of animals, administration of drugs, tissue sampling, and euthanasia were monitored by officially qualified animal care personnel.
Oral carbohydrate and fat load study. The effects of the major triterpene alcohols and sterols, and their esters from rice bran on the postprandial GIP response was examined in an oral carbohydrate and fat load study using C57BL/6J mice. Mice were assigned to nine groups (n ϭ 16 in each group): carbohydrate plus fat (control) and controls with CA, CA-O, CA-F, 24Me, 24Me-O, 24Me-F, SS, or CS (175 M, respectively). Starch (Amioka; National Starch, Tokyo, Japan) was gelatinized in distilled H 2O by an autoclave treatment (121°C, 2 atm for 20 min) and used as carbohydrate. Glyceryl trioleate (TO) was used as fat. Lecithin [from egg yolk, 0.04 mg/g body weight (BW), 0.2% in administered samples; Kanto Chemical, Tokyo, Japan] and albumin (0.2 mg/g BW, 1% in administered samples) were included in all test solutions, which were subsequently sonicated three times for 60 sec with a 1-min interval of cooling on ice to obtain stable emulsions (Sonifier 450, Branson Ultrasonics, Danbury, CT). The administration volume was adjusted to 20 mg/g BW. Overnight-fasted mice were anesthetized through the inhalation of isoflurane (Abbott Laboratories, North Chicago, IL) and gastrically administered 2 mg/g BW of carbohydrate and 1 mg/g BW of fat with or without triterpene alcohols, sterols, or their esters.
To examine the dose-dependence of CA, mice were assigned to five groups (n ϭ 8 in each group): carbohydrate alone and carbohydrate plus fat without (control) or with CA (0.5, 2.5, and 12.5 g/g BW).
Boiled Japonica white rice (Koshihikari) was homogenized with a handy micro homogenizer (Physcotron NS-310E, Microtec, Chiba, Japan) and used as carbohydrate. TO was used as fat. Lecithin (0.08 mg/g BW, 0.2% in administered samples) was included in all test solutions, which were subsequently sonicated as described above to obtain stable emulsions. The administration volume was adjusted to 20 mg/g BW. Overnight-fasted mice were anesthetized through the inhalation of isoflurane and gastrically administered 2 mg/g BW of carbohydrate and 2 mg/g BW of fat with or without CA.
In the fat load study, mice were assigned to three groups (n ϭ 8 in each group): fat alone (control) and fat with CA (2.5 and 5 g/g BW).
TO was used as fat. Lecithin (0.08 mg/g BW, 0.2% in administered samples) was included in all test solutions, which were subsequently sonicated as described above to obtain stable emulsions. The administration volume was adjusted to 20 mg/g BW. Overnight-fasted mice were anesthetized through the inhalation of isoflurane and gastrically administered 2 mg/g BW of fat with or without CA.
Blood samples were collected from the orbital sinus under anesthesia with isoflurane inhalation immediately before and at the indicated times after gastric gavage with a heparinized capillary tube (75-mm length) (Drummond Scientific, Broomall, PA). Blood samples were kept on ice until plasma preparation. After centrifugation at 3,500 g for 5 min at 4°C, plasma was stored at Ϫ80°C until analysis.
In vitro fatty acid uptake study with HuTu-80 cells. The human intestinal epithelial cell line, HuTu-80 cells (Cell Lines Service, Eppelheim, Germany) transfected with human SGLT-1 (36) , was used in the present study. Cells were seeded into 12-well plates at 5 ϫ 10 5 cells/well and grown to 95-100% confluence. The cells were then cultured in glucose-and FBS-free DMEM for 1 h before oleate uptake. Cells were washed twice with Dulbecco's PBS (DPBS) (GIBCO, Invitrogen, Carlsbad, CA) and then incubated in DPBS containing CaCl2 (1.8 mM) and MgCl2 (1 mM) [PBS (ϩ)] buffer with or without 0.5 mM SSO for 1 h at 37°C. To determine the effects of CA on oleate uptake, cells were incubated in PBS (ϩ) buffer containing [ 3 H]oleate (cat. no. NET289, 0.14 M, 1 Ci/ml; PerkinElmer, Tokyo, Japan), 50 M oleate, 1% TO, and 0.2% BSA with or without 2 mM of CA for 30 min at 37°C. The cells were then washed three times with DPBS and solubilized with 0.5 ml of 0.1 N NaOH. A total of 10 ml of Scintillation Cocktail (Hionic-Fluor, PerkinElmer) was added to the resultant cell lysate. The radioactivity of 3 H in the cell lysate was measured using an automatic liquid scintillation spectrometer (Tri-Carb 2550 TR/LL, Packard, Rungis, France).
High-Fat diet-induced obesity. Mice (8 wk old) were assigned to each of the indicated groups (n ϭ 12) ( Table 1) . Average body weights were adjusted among each group. Each group had free access to the semipurified powder diet ( Table 1 ). The composition of the respective diets was based on our previous study (26) . A dome-type cover on the feeding dish (Roden Cafe, Oriental Yeast, Tokyo, Japan) was used to avoid scattering of the powdered diet in the cage. The energy values for each diet were calculated from the macronutrient composition using values of 4, 4, and 9 kcal/g for carbohydrate, protein, and fat, respectively.
Mice were maintained for 23 wk. Individual body weights were monitored weekly. Food intake was measured on a per cage basis throughout the study every 3 or 4 days. Food intake was determined by subtracting the remaining food weight from the initial food weight on the previous feeding day. Energy intake was calculated from the food intake and macronutrient composition of each diet. Under nonfasting conditions, mice were anesthetized by the inhalation of isoflurane. Blood samples were collected from the abdominal vein into capillary blood collection tubes (Capiject with EDTA-2Na; Terumo Medical, Tokyo, Japan) and maintained on ice until the preparation of plasma. After centrifugation at 3,500 g for 10 min at 4°C, plasma samples were stored at Ϫ80°C until analysis. White adipose tissue (WAT) (epididymal, mesenteric, retroperitoneal, and perirenal), skeletal muscle (soleus and gastrocnemius), and the liver were removed and weighed. Total liver lipids were extracted by a previously described procedure (9), then dried under a stream of nitrogen and redissolved in 2-propanol/Triton X-100 (9:1) solution. Liver triglyceride (TG) content was determined by spectrophotometric methods (Triglyceride E-test; Wako Pure Chemical Industries).
Indirect calorimetry. Respiratory metabolic performance in the sedentary condition was measured with an indirect calorimetric system equipped with a sixteen-chamber airtight metabolic cage (Arco 2000; Arco System, Chiba, Japan). Airflow through the metabolic cage was adjusted to 0.4 l/min.
Mice were assigned to two groups (n ϭ 5 in each group), high-fat (HF) diet and HF diet supplemented with 0.5% TASP. Each group had free access to the diet in Roden Cafe. Data were collected continuously for 39 h with a settling time of 15 sec and a measuring time of 15 sec, and the reference was room air. Data was obtained for each chamber every 5 min.
The respiratory exchange ratio (RER) and substrate utilization were calculated from the measured values of oxygen consumption (V O2) and carbon dioxide production (V CO2) with previously conducted equations ( Distributions of dietary CA and 24Me in the blood and liver. Gelatinized starch (Amioka) was used as carbohydrate, and TO was used as fat. Lecithin (0.04 mg/g BW, 0.2% in the administered samples) and albumin (0.2 mg/g BW, 1% in the administered samples) were included in the test solution, and this was subsequently sonicated as described above to obtain stable emulsions. The administration volume was adjusted to 20 mg/g BW. Overnight-fasted mice were anesthetized through the inhalation of isoflurane and administered 2 mg/g BW of carbohydrate and 2 mg/g BW of fat, added with 50 g/g BW of TASP. The collection of blood from the abdominal vein was performed as described above, immediately before and at the indicated times after the administration to acquire plasma samples. The liver was removed and weighed, then stored at Ϫ80°C until analysis.
CA and 24Me concentrations in the plasma and liver were determined using a liquid chromatography-electrospray ionization-tandem mass spectrometer (LC-ESI-MS/MS). Purified CA or 24Me was used as a standard. Cholesterol-d7 (Avanti Polar Lipids, Alabaster, AL) was used as an internal standard. To prepare plasma samples for LC-ESI-MS/MS, 100 l of a plasma sample, 100 l of cholesterol-d7 (100 ng/ml), 400 l of methanol (Kanto Chemical), 500 l of chloroform, and 200 l ultrapure water (Milli-Q, Millipore, Tokyo, Japan) were added to a polypropylene tube and vortexed briefly. The mixture was then centrifuged at 4,500 g for 10 min at 5°C. The chloroform phase was collected and evaporated under a stream of nitrogen. The remaining residue was dissolved in 3 ml of 80% methanol, then loaded onto a silica gel cartridge column (InertSep C18, GL Science, Torrance, CA). The cartridge was rinsed with 80% ethanol and eluted with 2 ml of methanol/acetone/hexane (2:2:1, v/v/v). After evaporation of the solvent under a stream of nitrogen, the residue was reconstituted in 1 ml of 2-fluoro-1-methylpyridinium p-toluenesulfonate [0.5% in acetonitrile (v/v); Tokyo Chemical Industry, Tokyo, Japan] and 50 l of triethylamine (Wako Pure Chemical Industries), then incubated for 1 h at 80°C. After evaporation under a stream of nitrogen, the residue was reconstituted in 0.1 ml of the mobile phase [0.5% formic acid/60% acetonitrile in water (v/v/v)]. To prepare liver samples, whole liver, 100 l of cholesterol-d7 (100 ng/ml), and 2.4 ml of methanol were added to polypropylene tubes and homogenized. A total of 2.5 ml of chloroform and 1 ml of ultrapure water were added to the homogenate, which was vortexed briefly, then centrifuged at 4,500 g for 10 min at 5°C. After the chloroform phase was collected, the rest of the procedure was carried out as described above for plasma samples. Ten microliters of each prepared sample was used for LC-ESI-MS/MS analysis. The LC conditions were as follows: LC system, UltiMate 3000 system (Dionex, Germering, Germany); Column, Inertsil ODS-3 (2.1 mm ϫ 150 mm, 3 m; GL Science); column temperature ϭ 40°C; Mobile phase, 0.5% formic acid/60% acetonitrile in water (v/v); flow rate ϭ 0.2 ml/min; auto sampler temperature ϭ 5°C; total runtime ϭ 25 min per sample. The MS/MS conditions were as follows: MS system, QTRAP 5500 (AB SCIEX, Toronto, Canada); ionization, ESI positive; analysis mode, MRM; CAD ϭ 7; CUR ϭ 50 psi; GS1 ϭ 50 psi; GS2 ϭ 50 psi; IS ϭ 5,500 V.
In vitro gene expression study with HepG2 cells. The human hepatocellular liver carcinoma cell line (HepG2) was purchased from the American Type Culture Collection (Manassas, VA). Cells were cultured in DMEM supplemented with 10% FBS and 1% antibiotics. Cells were then seeded in 12-well plates at a density of 5 ϫ 10 5 cells/well, then incubated to reach subconfluence (70 -80%). After an overnight incubation with serum-free DMEM, the cells were washed twice with DPBS, then DMEM containing 10% FBS, 1% antibiotics, and 0.5% DMSO with or without 7 M of CA or 24Me was added and cells were incubated at 37°C. After the 24-h incubation, the cells were washed three times with DPBS and lysed with a lysis solution (RNeasy Mini Kit, Qiagen, Tokyo, Japan). Total RNA was then extracted as described below.
Plasma analysis. Plasma insulin was determined with a Rat/Mouse Insulin ELISA kit and rat insulin as standard (Morinaga Institute of Biological Science, Kanagawa, Japan). Plasma total GIP and leptin were measured with a Milliplex Kit for mouse gut hormones (Mouse Gut Hormone Milliplex Kit, Millipore). Plasma total cholesterol (T-Cho), TG, and nonesterified fatty acids (NEFA) were determined by spectrophotometric methods [N-assay L T-CHO-H (Nittobo, Tokyo, Japan), Triglyceride E-test, and NEFA-C test (Wako Pure Chemical Industries), respectively]. Blood glucose was determined with a blood glucose self-monitoring device (Accu-Chek Aviva, Roche Diagnostics, Tokyo, Japan) immediately after blood collection. Quantitative RT-PCR. Total RNA was extracted from the mouse liver, skeletal muscle, and HepG2 cells with the RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. Total RNA was extracted from mouse WAT with the RNeasy Lipid Mini kit (Qiagen) according to the manufacturer's instructions. cDNA was produced from 1 g of total RNA with the SuperScript First-Strand Synthesis System for RT-PCRs (Invitrogen). Quantitative real-time PCR was performed with the Applied Biosystems 7500 Real-Time PCR System and TaqMan Gene Expression Assay (Applied Biosystems, Tokyo, Japan) according to the manufacturer's instructions. A predesigned primer and fluorescent probe sets (Table 2) were purchased from Applied Biosystems. The same amount of total RNA was consistently used for each expression analysis to ensure quantitative precision, and the expression level of each gene was normalized to the expression of a housekeeping gene, ribosomal protein, large, P0 (Rplp0/36B4).
Statistical analysis. Numerical data are expressed as means Ϯ SE. Statistical analysis was conducted with the Student's t-test or one-way ANOVA followed by Dunnett's post hoc test. The Jonckheere trend test (18) was conducted to evaluate dose dependencies. Data analyses were performed using the statistical software StatView for Windows (version 5.0, SAS Institute, Cary, NC) and R (version 3.0.2, R Foundation for Statistical Computing, Vienna, Austria). Differences were considered significant when the error probability was smaller than 0.05.
RESULTS
Triterpene alcohols and sterols decreased the diet-induced
GIP response in C57BL/6J mice. After the carbohydrate and fat had been administered by gavage to overnight-fasted mice, plasma GIP levels peaked by 10 min and thereafter declined, returning close to baseline levels after 120 min (Fig. 1A) . The coadministration of CA significantly decreased the elevations in plasma GIP levels observed at 10 min and 30 min (Fig. 1A) . CA, but not its oleic acid or ferulic acid ester, significantly decreased the postprandial GIP response [maximum concentration (Cmax) 10 min after gastric gavage] in mice after the gastric gavage of carbohydrate and fat (CA, CA-O, and CA-F, respectively; Fig. 1B ). 24Me as well as its oleic acid and ferulic acid ester slightly decreased the postprandial GIP response (24Me, 24Me-O, and 24Me-F, respectively; Fig. 1B ). SS and CS also decreased the postprandial GIP response in mice (SS and CS, respectively; Fig. 1B) .
CA decreased carbohydrate plus fat-induced postprandial GIP response in mice. After the administration of carbohydrate plus fat by gavage to overnight-fasted mice, plasma GIP levels at 10 min, 30 min, 60 min, and the plasma GIP response for 60 min [area under the curve (AUC) GIP 60 min] were significantly higher than those after the administration of carbohydrate alone (Fig. 2, A and B) . However, the coadministration of CA decreased the fat-promoted plasma GIP response (AUC) in a dose-dependent manner (P Ͻ 0.05, by the Jonckheere trend test), and a significant decrease was observed following the coadministration of 12.5 g/g BW of CA (Fig. 2B) .
CA decreased the fat-induced postprandial GIP response in mice. Plasma GIP concentrations increased 15 min after the fat emulsion was administered by gavage to overnight-fasted . Each blood sample was collected 0, 10, 30, 60, and 120 min after gavage, and Cmax was defined as the maximum plasma GIP level among the five sampled points. Cmax was equivalent to the concentration observed 10 min after gastric gavage. Data are expressed as means Ϯ SE; n ϭ 16 in each group; *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001 significantly different from the control group (one-way ANOVA followed by Dunnett's post hoc test).
mice, and thereafter declined, almost reaching the baseline after 60 min (Fig. 3A) . The supplementation of CA significantly decreased the fat-induced plasma GIP response for 60 min (AUC GIP 60 min) in a dose-dependent manner (P Ͻ 0.01, by the Jonckheere trend test; Fig. 3B ).
CA inhibited fatty uptake into Hutu-80 cells.
The cellular uptake activity of radiolabeled oleate was significantly lower in CA-treated cells than in controls (ϪSSO; Fig. 3C ). The pretreatment of cells with the FAT/CD36 inhibitor SSO reduced the uptake activity of radiolabeled oleate, and uptake activity was further reduced by the addition of CA (ϩSSO; Fig. 3C ).
TASP ingestion attenuated high-fat diet-induced body weight gain and visceral fat accumulation in mice.
The body and visceral WAT weights of mice fed a HF diet for 23 wk were significantly higher than those of mice fed a low-fat diet, while those of mice fed a HF diet supplemented with 0.2, 0.5, and 1% TASP were significantly lower than those of the corresponding HF diet mice (Fig. 4, A-C) . Liver weights and liver TG contents were also significantly lower in the 0.2, 0.5, and 1% TASP-fed mice than in the corresponding HF diet-fed mice (Fig. 4, D and E) . Supplementing the HF diet with 0.2, 0.5, and 1% TASP significantly reduced nonfasting plasma leptin concentrations (Table 3) . Supplementing the HF diet with 0.5 and 1% TASP significantly reduced nonfasting plasma T-Cho concentrations and slightly decreased plasma insulin concentrations (Table 3) . No significant differences were observed in energy intakes between the TASP-supplemented and corresponding HF diet-fed groups (Fig. 4F) .
Dietary TASP promoted fat utilization in HF diet-fed mice. Indirect calorimetry revealed that oxygen consumption did not differ between the groups (Fig. 5A) . RER was slightly lower in by gavage to overnight-fasted C57BL/6J mice were determined. Data are expressed as means Ϯ SE; n ϭ 8 in each group; *P Ͻ 0.05 and ***P Ͻ 0.001 significantly different from the control group (one-way ANOVA followed by Dunnett's post hoc test). The P value for the trend (Ptrend) was calculated using the Jonckheere trend test. , liver triglyceride (TG) contents (E), and energy intake (F). C57BL/6J mice were fed a low-fat (LF) diet (white circles), high-fat (HF) diet (black circles), or HF diet supplemented with 0.04% (white squares), 0.2% (black squares), 0.5% (white triangles), or 1% (black triangles) TASP for 23 wk. Data are expressed as means Ϯ SE; n ϭ 12 in each group; *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001 significantly different from the HF diet-fed group (one-way ANOVA followed by Dunnett's post hoc test).
the TASP-fed group than in the corresponding HF diet-fed control group (Fig. 5B) . While total energy expenditure during the experimental period did not differ between the groups (Fig.  5C ), fat utilization was significantly higher in the TASP-fed group than in the control group (Fig. 5D) . No significant differences were observed in dietary intake during the experimental period between the groups (30.42 Ϯ 0.47 and 30.58 Ϯ 2.34 kcal/mouse, respectively). Furthermore, no significant differences were noted in body weight gain in mice during the experimental period between the groups (0.45 Ϯ 0.09 and 0.38 Ϯ 0.21 g, respectively).
Dietary TASP increased fatty acid oxidation-related gene expression in the skeletal muscle, and decreased fatty acid synthesis-related gene expression in the livers of HF dietfed mice
. After a 7-wk feeding protocol, the expression levels of fatty acid oxidation-related genes, such as acylCoA oxidase (ACO) and carnitine palmitoyltransferase I (CPT1), in the soleus muscles were significantly or slightly higher in TASP-fed mice than in the corresponding HF diet-fed mice (Fig. 6, A and B) . In contrast, no significant difference was observed in the expression of these genes in the liver between the HF diet-fed groups (Fig. 6, E and F) . On the other hand, the expression levels of fatty acid synthesis-related genes, such as sterol regulatory elementbinding protein-1c (SREBP-1c) and fatty acid synthase (FAS), in the liver were significantly lower in 0.5% TASPfed mice than in the corresponding HF-fed mice (Fig. 6, G  and H) , while no significant difference was noted in the expression levels of these genes in the soleus muscle (Fig. 6,  C and D) . In epididymal fat, no significant difference was observed in the expression levels of fatty acid metabolismrelated genes among the HF diet-fed groups (Fig. 6, I-L) . Data are expressed as means Ϯ SE; n ϭ 12 in each group. T-Cho, total cholesterol; TG, triglycerides; NEFA, nonesterified fatty acids. *P Ͻ 0.05, and **P Ͻ 0.01 significantly different from the control HF group (one-way ANOVA followed by Dunnett's post hoc test). • Fig. 5 . Effects of dietary TASP on energy homeostasis in mice. Oxygen consumption (V O2) (A), the respiratory exchange ratio (RER) (B), energy expenditure (C), and fat utilization (D) in C57BL/6J mice in metabolic chambers for 39 h, under free access to a HF diet or HF diet supplemented with 0.5% TASP. Data are expressed as means Ϯ SE; n ϭ 5 in each group; *P Ͻ 0.05 significantly different between the groups; N.S., not significant (t-test). (Fig. 7A) . Similar results were obtained for the hepatic concentration of CA (Fig. 7B) . The plasma and hepatic concentrations of 24Me also peaked at 3 h and 6 h, respectively, then decreased (Fig. 7, C and D) .
CA and 24Me reduced fatty acid synthesis-related gene expression in HepG2 cells. SREBP-1c gene expression levels in HepG2 cells after a 24-h incubation were significantly lower following the addition of 7 M of CA or 24Me to the medium than in the nonadditive control (Fig. 8) . Between the two triterpene alcohols, the effects of CA were stronger than that of 24Me (Fig. 8) .
DISCUSSION
The present study demonstrated that supplementation with TASP from rice bran attenuated postprandial blood GIP increases after the ingestion of macronutrients (Fig. 2) and HF diet-induced body weight gain as well as visceral fat and liver triglyceride accumulation in diet-induced obesity in mice (Fig.  4) . Dietary TASP also attenuated high-fat diet-induced hyperleptinemia and hypercholesterolemia (Table 3 ). Since leptin is secreted by adipose tissues, blood leptin levels are associated with the accumulation of body fat (1), and hypercholesterolemia is closely related to obese phenotypes (7), the lower blood leptin and cholesterol levels observed in the present study may have been due to a reduction in the accumulation of body fat after 23 wk of ingesting TASP.
The results of indirect calorimetry suggested the underlying mechanism for the antiobesity effects of TASP; an increase in fat utilization due to supplementation with TASP may be responsible for its antiobesity activity. Previous studies indicated that GIP may contribute to the regulation of energy expenditure (3, 24, 37) . We previously demonstrated that the chronic administration of GIP decreased fat utilization under HF diet-fed conditions in rodents (37) . In addition, GIPR ablation increased fat utilization and prevented HF diet-induced obesity in mice (24) . The ablation of GIP-secreting K cells enhanced energy expenditure and reduced HF diet-in- duced obesity in mice (3). Our recent study showed that RS4-type resistant starches and 1-monoolein reduced postprandial GIP and insulin responses, resulting in an increase in fat utilization and reduced HF diet-induced obesity in mice (36, 37) . The present results are consistent with the findings of previous studies and suggest that the reduction in postprandial blood GIP levels by TASP enhanced fat utilization, thereby preventing HF diet-induced obesity. Increased fat utilization due to the ingestion of TASP may have been due to a decrease in blood insulin levels. However, we previously demonstrated that the chronic administration of GIP decreased fat utilization without changing plasma insulin levels (37) . Moreover, the results of the present study showed that dietary TASP did not alter nonfasting blood insulin levels in high-fat diet-fed mice. Therefore, increased fat utilization after the ingestion of TASP was not insulin-dependent. Gene expression analysis of the skeletal muscle and liver of TASP-fed mice provided a more detailed insight into the mechanisms underlying the antiobesity effects of dietary TASP. Dietary TASP upregulated a fatty acid oxidation-related gene including MCAD (after 2 wk, data not shown) and CPT1 (after 7 wk, Fig. 6B ) in the soleus muscle. These changes in skeletal muscular gene expression may have contributed to increased fat utilization due to dietary TASP. Even though GIPR expression was absent in the skeletal muscle of mice (our unpublished data), GIPR ablation increased serum adiponectin levels, which resulted in an increase in fat oxidation in skeletal muscle (27, 46) . Although we did not examine adiponectin levels following the ingestion of TASP, the present results suggest that skeletal muscle may be responsible for the increased fat utilization by dietary TASP. Moreover, the fatty acid synthesis-related genes SREBP-1 and FAS were downregulated in the liver. GIPR expression was also shown to be absent in the liver (40, 41, 45) . Even though the expression of both the SREBP-1c and FAS genes was previously reported to be directly regulated by insulin (28), a decrease in the expression of these genes due to the ingestion of TASP may also be insulin-independent because nonfasting blood insulin levels were not altered by the ingestion of TASP. The present results demonstrated that dietary triterpene alcohols (CA and 24Me) were absorbed into the circulation. Each triterpene alcohol decreased SREBP-1 gene expression in the human hepatocyte cell line (HepG2), which suggests that dietary triterpene alcohols directly decreased SREBP-1 levels in the liver. CA decreased hepatic SREBP-1 levels more than 24Me. After the ingestion of TASP, the concentration of CA was higher than that of 24Me in the liver. Taken together, these results indicate that CA may be the major active component that decreases hepatic SREBP-1 after the ingestion of TASP. Insulin may also be responsible for enhanced hepatic SREBP-1 and FAS gene expression (10, 31) . However, other molecules regulated by insulin, such as ACO, CPT1 in the liver, and fatty acid synthesis-related genes in adipose tissue, remained unchanged. Therefore, reduced insulin levels after the ingestion of TASP may not be responsible for the changes observed in gene expression.
Previous studies reported that fat is a potent secretagogue of GIP release (8, 35) . CA was shown to attenuate fat-promoted GIP secretion in mice (Fig. 3) . Our previous study also demonstrated that fat-induced GIP secretion was triggered by fatty acid transport via FAT/CD36, which is located in GIP-producing K cells (36) . Extracellular CA reduced fatty acid transport in FAT/CD36-expressing human enteroendocrine cells (Hutu-80). More importantly, cellular fatty acid transport was further reduced by CA, even when cells were treated with a FAT/ CD36 inhibitor (SSO), which suggested that the inhibitory effect of CA on fatty acid transport may be independent of FAT/CD36. G protein-coupled fatty acid receptors, such as GPR40, 119, and 120, were recently suggested to play a role in the regulation of enteroendocrine hormone release (4, 14, 30) . However, the molecular mechanisms responsible for the reduced release of GIP by TASP have yet to be elucidated.
Even though dietary CA reduced fatty acid transport into enteroendocrine cells, dietary supplementation with either TASP or CA did not alter postprandial blood TG increases (data not shown) or nonfasting blood TG levels (Table 3) . These results suggest that the antiobese effects of dietary supplementation with TASP were not due to a reduction in the digestibility or absorption of macronutrients.
Several studies in humans and animals clarified the beneficial effects of triterpene alcohols and their derivatives from rice bran. For example, ␥-oryzanol, a mixture of the ferulic acid esters of triterpene alcohols and sterols in rice bran, was shown to have various biological effects, such as cholesterol-lowering (33), anti-inflammatory (2), anticancer (44) , and antidiabetic effects (38) . More recently, ␥-oryzanol was reported to reduce dietary fat preferences by attenuating HF diet-induced endoplasmic reticulum stress in the hypothalamus, resulting in the amelioration of HF diet-induced obesity in mice (22) . In the present study, the intake of food did not change with the TASP supplementation, which indicated that the antiobese effects of TASP were independent of eating behavior patterns.
To prevent diet-induced obesity, we focused on reducing the postprandial release of GIP. Rice bran-derived, oil-soluble TASP can be added to a wide variety of foods. Therefore, supplementing food with TASP may represent a good approach to improve diet-induced obesity. Given that rice is now a staple worldwide, the enrichment of TASP in brown rice and rice bran by chemical or biological processing may be an alternative way to develop obesity-preventative foods.
In conclusion, the present study demonstrated for the first time that TASP from rice bran increased the postprandial utilization of fat and attenuated diet-induced obesity via GIPdependent and GIP-independent mechanisms. These results are important for the further development of GIP-based therapies to treat obesity. Therefore, more detailed studies on the kinetics of GIP should be undertaken in relation to energy homeostasis in larger animals and humans.
GRANTS
The present study was supported financially by the Kao Corporation.
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the author(s). 
AUTHOR CONTRIBUTIONS
